Total Payments
$645,484
2024 Payments
$18,279
Companies
18
Transactions
882
Medicare Patients
6,644
Medicare Billing
$833,621
Payment Breakdown by Category
Other$538,146 (83.4%)
Travel$80,882 (12.5%)
Consulting$14,894 (2.3%)
Food & Beverage$11,224 (1.7%)
Education$338.54 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $533,221 | 351 | 82.6% |
| Travel and Lodging | $80,882 | 214 | 12.5% |
| Consulting Fee | $14,894 | 10 | 2.3% |
| Food and Beverage | $11,224 | 286 | 1.7% |
| Compensation for serving as faculty or as a speaker for a medical education program | $4,925 | 7 | 0.8% |
| Education | $338.54 | 14 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $267,791 | 277 | $0 (2024) |
| Lilly USA, LLC | $169,303 | 297 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $104,967 | 143 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $31,796 | 28 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $29,986 | 39 | $0 (2023) |
| Amarin Pharma Inc. | $20,909 | 32 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $8,299 | 17 | $0 (2017) |
| Abbott Laboratories | $5,598 | 32 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $5,499 | 6 | $0 (2023) |
| IBSA Pharma Inc. | $1,000 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,279 | 32 | Novo Nordisk Inc ($10,215) |
| 2023 | $24,849 | 36 | Novo Nordisk Inc ($13,432) |
| 2022 | $42,664 | 49 | Novo Nordisk Inc ($28,705) |
| 2021 | $40,820 | 74 | Novo Nordisk Inc ($18,870) |
| 2020 | $58,895 | 97 | Lilly USA, LLC ($24,822) |
| 2019 | $131,386 | 181 | Lilly USA, LLC ($51,205) |
| 2018 | $155,038 | 178 | Novo Nordisk Inc ($80,503) |
| 2017 | $173,553 | 235 | Novo Nordisk Inc ($51,003) |
All Payment Transactions
882 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $6.56 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: DIABETES | ||||||
| 09/03/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $4.75 | General |
| Category: DIABETES | ||||||
| 06/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $4.83 | General |
| Category: DIABETES | ||||||
| 06/12/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: Diabetes | ||||||
| 04/15/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 04/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: Diabetes | ||||||
| 04/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: DIABETES | ||||||
| 04/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: DIABETES | ||||||
| 04/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: DIABETES | ||||||
| 04/01/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,754.50 | General |
| Category: Diabetes | ||||||
| 03/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: Diabetes | ||||||
| 03/25/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 03/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: Diabetes | ||||||
| 03/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Travel and Lodging | Cash or cash equivalent | $60.00 | General |
| Category: Diabetes | ||||||
| 03/06/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Travel and Lodging | Cash or cash equivalent | $87.10 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $30.20 | General |
| Category: Diabetes | ||||||
| 02/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Diabetes | ||||||
| 02/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $41.78 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,368 | 5,430 | $763,412 | $169,786 |
| 2022 | 14 | 1,542 | 6,043 | $630,505 | $196,545 |
| 2021 | 16 | 1,796 | 6,326 | $723,653 | $232,630 |
| 2020 | 20 | 1,938 | 6,878 | $837,742 | $234,660 |
Total Patients
6,644
Total Services
24,677
Medicare Billing
$833,621
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 641 | 928 | $363,243 | $73,432 | 20.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 33 | 3,060 | $212,870 | $56,145 | 26.4% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2023 | 122 | 296 | $49,389 | $10,656 | 21.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 163 | 263 | $28,187 | $6,501 | 23.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $26,263 | $5,064 | 19.3% |
| G0109 | Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | Office | 2023 | 35 | 435 | $22,647 | $4,931 | 21.8% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 87 | 90 | $22,577 | $4,748 | 21.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 37 | $10,409 | $2,169 | 20.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 69 | 69 | $12,246 | $1,800 | 14.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 25 | 25 | $2,519 | $1,798 | 71.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 45 | 113 | $6,176 | $1,200 | 19.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $815.75 | $729.25 | 89.4% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 16 | 16 | $4,563 | $309.60 | 6.8% |
| 72080 | X-ray of middle and lower spine, 2 views | Office | 2023 | 21 | 21 | $1,507 | $303.87 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 708 | 1,068 | $279,436 | $87,400 | 31.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 38 | 3,540 | $172,551 | $60,274 | 34.9% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2022 | 167 | 402 | $52,620 | $15,378 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $27,600 | $7,870 | 28.5% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 106 | 110 | $14,850 | $5,649 | 38.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 129 | 208 | $18,512 | $5,235 | 28.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 72 | $12,639 | $4,342 | 34.4% |
| G0109 | Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | Office | 2022 | 22 | 300 | $19,500 | $3,336 | 17.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 86 | 86 | $17,114 | $2,264 | 13.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 32 | 32 | $2,926 | $2,121 | 72.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 37 | 37 | $1,295 | $1,040 | 80.3% |
About Dr. Nilay Desai, MD
Dr. Nilay Desai, MD is a Internal Medicine healthcare provider based in Rocky Mount, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336157122.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nilay Desai, MD has received a total of $645,484 in payments from pharmaceutical and medical device companies, with $18,279 received in 2024. These payments were reported across 882 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($533,221).
As a Medicare-enrolled provider, Desai has provided services to 6,644 Medicare beneficiaries, totaling 24,677 services with total Medicare billing of $833,621. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Rocky Mount, NC
- Active Since 08/04/2006
- Last Updated 03/08/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1336157122
Products in Payments
- JARDIANCE (Drug) $136,020
- TRULICITY (Drug) $120,428
- Ozempic (Drug) $79,788
- Tresiba (Drug) $62,871
- Victoza (Drug) $32,398
- Rybelsus (Drug) $30,718
- RYBELSUS (Drug) $27,617
- SOLIQUA (Drug) $24,425
- FARXIGA (Drug) $22,597
- Vascepa (Drug) $20,909
- Xultophy 100/3.6 (Drug) $15,494
- BYDUREON (Drug) $9,199
- INVOKANA (Drug) $8,293
- TOUJEO (Drug) $5,509
- Kerendia (Drug) $5,499
- FreeStyle Libre Pro (Device) $3,575
- FREESTYLE LIBRE 2 (Device) $1,530
- Tirosint (Drug) $1,000
- FREESTYLE LIBRE 3 (Device) $379.90
- Xultophy (Drug) $220.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rocky Mount
Xiang Wang, M.d, M.D
Internal Medicine — Payments: $13,368
Internal Medicine $13,368
Sheetal Patel, D.o, D.O
Internal Medicine — Payments: $5,592
Internal Medicine $5,592
Gerrie Shiver, Md, MD
Internal Medicine — Payments: $4,524
Internal Medicine $4,524
David Browder, Md, MD
Internal Medicine — Payments: $3,001
Internal Medicine $3,001
Shwetha Rupendu
Internal Medicine — Payments: $2,833
Internal Medicine $2,833
Dr. Yasmin Heater Williamson, Md, MD
Internal Medicine — Payments: $2,498
Internal Medicine $2,498